A Retrospective Data Collection on NobelProcera® Zirconia Implant Bridges from 4 to 14 Units.
Active, not recruiting
- Conditions
- Dental Prosthesis, Implant-Supported
- Interventions
- Other: observational study, no intervention is required
- Registration Number
- NCT06600451
- Lead Sponsor
- Nobel Biocare
- Brief Summary
This is a retrospective multicenter data collection in which clinical and radiographic data on implant zirconia bridges are collected from partially or fully edentulous subjects consecutively treated with at least one 4- to 14-unit NobelProcera® Zirconia Implant Bridge. This data collection will be conducted in up to 11 centers (see Appendix I) and will include between 150 to 200 subjects.
The aim of this retrospective multicenter data collection is to evaluate the safety, performance, and clinical benefits of NobelProcera® Zirconia Implant Bridges (4 to 14 units) in daily dental practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Subject was at least 18 years old at the time of treatment,
- Subjects treated with at least one NobelProcera® Zirconia Implant Bridge (4- to 14-unit supported by 2 to 10 implants).
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients treated with NobelProcera Zr Implant Bridge (4-14-unit) observational study, no intervention is required Patients partially and fully edentulous in need of the implant supported dental prosthesis treated with NobelProcera Zr Implant Bridge (4-14-unit) from June 2020. Device is CE and available on the market in May 2020.
- Primary Outcome Measures
Name Time Method complications from bridge placement to last follow-up (up to 36 months follow-up) biological and technical complications
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Nobel Biocare Sevices AG
🇨🇭Kloten, Switzerland